Live Breaking News & Updates on Synagis

Stay updated with breaking news from Synagis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SYNAGIS (Palivizumab) for Respiratory Syncytial Virus (RSV)

Dublin, April 30, 2024 (GLOBE NEWSWIRE) The ....

United-kingdom , United-states , Germany , Japan , Dublin , Ireland , Italy , France , Spain , Clinical-development , Market-insight

SYNAGIS (Palivizumab) for Respiratory Syncytial Virus (RSV) in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2023 & 2023-2032

Dublin, April 30, 2024 (GLOBE NEWSWIRE) The "SYNAGIS Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about SYNAGIS for Respiratory syncytial virus (RSV) in the seven major markets. A detailed picture of the SYNAGIS for RSV in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019-2032 is provided in this report ....

United-kingdom , United-states , Germany , Japan , Dublin , Ireland , Italy , France , Spain , Clinical-development , Market-insight

El Paso Children's Hospital warns of surge in RSV, influenza, and coronavirus cases

El Paso Children's Hospital reported a jump in the number of positive cases of RSV, Influenza, and Coronavirus. ....

Texas , United-states , El-paso , Jeffrey-schuster , Chief-medical-officer , Paso-children , Health-medical-pharma , Synagis , Human-interest , Palivizumab , El-paso-children-x27s-hospital , Biotechnology

Infant RSV Antibody Shortage: Here Are The CDC Recommended Alternatives

100 milligram doses of nirsevimab are in short supply, though supplies for the 50 milligram doses aren t affected. ....

United-states , New-york , American , Centers-for-disease , Astrazeneca , Drug-administration , New-york-times , Disease-control , American-indian , Antibody-for , After-brutal

First RSV Vaccine For Infants Approved By CDC And FDA: Other Top Vaccines And Their Effectiveness

Most people are expected to contract RSV by the age of two, though no vaccine has yet to be approved. ....

Barney-graham , Johnson , Vaccines-expected-within-months-everyday-health , Drug-administration , Astrazeneca , Morehouse-school-of-medicine , Pfizer , Morehouse-school , For-older-adults , New-england-journal , European-commission , After-brutal